Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Nature Genetics|May 7, 2021
Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's diseaseGanqiang Liu, Jiajie Peng, Zhixiang Liao, et al.
Medrxiv : the Preprint Server for Health Sciences|October 4, 2023
Dopamine pathway and Parkinson's risk variants are associated with levodopa-induced dyskinesiaYuri L Sosero, Sara Bandres-Ciga, Bart Ferwerda, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 12, 2024
Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa-Induced DyskinesiaYuri L Sosero, Sara Bandres-Ciga, Bart Ferwerda, et al.
The Journal of Headache and Pain|August 15, 2025
Longitudinal assessment of migraine burden in resistant and refractory migraine - Data from the prospective REFINE studyUmberto Pensato, Raffaele Ornello, Chiara Rosignoli, et al.
NPJ Parkinson'S Disease|May 14, 2026
Multi-locus genetic dosage shapes cognitive disease progression in Parkinson's patients: 15-year meta-analysis of 24 cohortsXiaoying Kang, Zechuan Lin, Fatma Zehra Calikusu, et al.
Brain : a Journal of Neurology|August 6, 2026
Defining the underlying pathology of corticobasal syndrome using clinical features and biomarkersDavid P Vaughan, Marte Theilmann Jensen, Raquel Real, et al.
Parkinsonism & Related Disorders|April 8, 2018
Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patientsMatej Skorvanek, Pablo Martinez-Martin, Norbert Kovacs, et al.
Brain : a Journal of Neurology|July 5, 2014
Parkinson's disease in GTP cyclohydrolase 1 mutation carriersNiccolò E Mencacci, Ioannis U Isaias, Martin M Reich, et al.
The Lancet. Neurology|September 20, 2025
Candesartan versus placebo for migraine prevention in patients with episodic migraine: a randomised, triple-blind, placebo-controlled, phase 2 trialLise Rystad Øie, Tore Wergeland, Øyvind Salvesen, et al.
Movement Disorders Clinical Practice|October 27, 2018
Differences in MDS-UPDRS Scores Based on Hoehn and Yahr Stage and Disease DurationMatej Skorvanek, Pablo Martinez-Martin, Norbert Kovacs, et al.
Pageof 12